某院182例严重药品不良反应/事件分析

doi:10.19803/j.1672-8629.2020.11.12

中国药物警戒 ›› 2020, Vol. 17 ›› Issue (11): 803-807.
DOI: 10.19803/j.1672-8629.2020.11.12

某院182例严重药品不良反应/事件分析

吴文利¹, 景晶¹, 陆钊罡¹, 张桂香², 王健¹, 王晓旭¹, 王基云^1,*

¹宁夏回族自治区人民医院,西北民族大学第一附属医院临床药学科,宁夏银川 750021;
²宁夏回族自治区人民医院,西北民族大学第一附属医院内分泌科,宁夏银川 750021

收稿日期:2020-11-10 修回日期:2020-11-10 出版日期:2020-11-15 发布日期:2020-11-10
通讯作者: ^*王基云,男,硕士,主管药师,临床药学及药事管理。E-mail:wangjiyundemail@163.com
作者简介:吴文利,女,硕士,主管药师,临床药学及医院药品不良反应监测。
基金资助:
宁夏科技惠民专项项目（2019CMG03008）:他汀类药物合理应用与药学服务标准化示范

Analysis of 182 Case of Serious Adverse Drug Reactions/events Reports in a Hospital

WU Wenli¹, JING Jing¹, LU Zhaogang¹, ZANG Guixiang², WANG Jian¹, WANG Xiaoxu¹, WANG Jiyun^1,*

¹Department of Clinical Pharmacy, People's Hospital of Ningxia Hui Autonomous Region /First Affiliated Hospital of Northwest University for Nationalities, Yinchuan Ningxia 750021,China;
²Department of Endocrinology, People's Hospital of Ningxia Hui Autonomous Region /First Affiliated Hospital of Northwest University for Nationalities, Yinchuan Ningxia 750021, China

Received:2020-11-10 Revised:2020-11-10 Online:2020-11-15 Published:2020-11-10

摘要/Abstract

摘要： 目的分析某院上报的严重药品不良反应/事件的发生特点,为临床安全用药提供参考。方法回顾性分析某院上报的182例严重药品不良反应/事件报告,对涉及药物种类、给药途径、转归、累及系统-器官以及临床表现进行分析。结果 182例报告中男性90例,女性92例;15~44岁占比最大（35.71%）;涉及药品种类中抗感染药物占比最高（28.04%）,其次为中成药制剂及中枢神经系统用药;累及系统-器官以肝胆损害、全身性损害、皮肤及其附件损害最多;临床表现以肝功能异常、肝酶升高、过敏性休克最为常见。结论抗感染药物、中成药制剂仍是严重药品不良反应/事件的监测重点;加强对45岁以上中老年患者长期联合用药的肝肾功能监测,确保患者用药安全。

关键词: 药品不良反应, 药品不良事件, 严重, 用药安全

Abstract: Objective To analyze the characteristics of serious adverse drug reactions/events (ADR/AE) reported in one hospital so as to provide reference for rational drug use in clinical practice. Methods One hundred and eighty-two reports of serious ADR/AE in one hospital were retrospectively analyzed, while drug categories, routes of administration, prognosis, systems or organs involved and clinical manifestations were studied. Results Among the 182 cases, 90 were males and 92 were females, and the group aged 15 to 44 accounted for 35.71%. According to categories, antimicrobial drugs ranked first (28.04%), followed by Chinese patent medicines and central nervous system drugs. Hepatobiliary disorders, general disorders, skin and appendages disorders were the most common involved systems organ classes(SOCs). The main clinical manifestations were abnormal hepatic function, increased hepatic enzymes, and anaphylactic shock. Conclusion Antimicrobial drugs and Chinese patent medicines remain the focus of monitoring of serious ADR/AE. Patients over 45 years old who have taken more than one drug for a long time should be monitored for liver and kidney function to ensure medication safety．

Key words: adverse drug reactions(ADR), adverse drug events(AE), serious, Safe medication

中图分类号:

R994.11

吴文利, 景晶, 陆钊罡, 张桂香, 王健, 王晓旭, 王基云. 某院182例严重药品不良反应/事件分析[J]. 中国药物警戒, 2020, 17(11): 803-807.

WU Wenli, JING Jing, LU Zhaogang, ZANG Guixiang, WANG Jian, WANG Xiaoxu, WANG Jiyun. Analysis of 182 Case of Serious Adverse Drug Reactions/events Reports in a Hospital[J]. Chinese Journal of Pharmacovigilance, 2020, 17(11): 803-807.

参考文献

[1] Wang J, Yu LL, Li W.Analysis of 358 cases of serious adverse drug reactions/events in Nanjing[J]. Drug Evaluation Research(药物评价研究),2018,41(12):2221-2226.
[2] Wang YC, Peng L, Luo FY, et al.Analysis of 139 cases of new and serious adverse drug reactions/events[J]. Ningxia Med J(宁夏医学杂志),2016,38(11):1078-1080.
[3] Chen XQ, Jin YY, Tang G, et al.New Edited Materia Medica[M]. 17th Edition. Beijing: People's Medical Publishing House(人民卫生出版社), 2018: 1-938.
[4] National Center for ADR Monitoring, Center for Drug Reevaluation. WHO Adverse Reaction Terminology[M]. Beijing: China Medical Science and Technology Publishing House(中国医药科技出版社),2003:3-172.
[5] Liu H,Zhou JC,Fan GR, et al.Pareto diagram analysis of 128 cases of serious adverse drug reactions from 2013 to 2016 in Shanghai First Hospital Affiliated to Shanghai Jiaotong University[J].Pharm Care Res(药学服务与研究), 2018, 18(5):385-388.
[6] Bao HL, Li JF, Wu ZA.Analysis on Influencing Factors of Quality of Adverse Drug Reaction Reports in China[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018,15(4):226-229.
[7] Niu LL, Li B, Li XL.Considerations about Present Situation of Hospital ADR Mornitoring[J].Chinese Journal of Pharmacovigilance(中国药物警戒), 2014,11(7):416-419.
[8] Zhao X, Lin P, Guo J, et al.Pareto Chart Analysis of Irrational Drug Use in Outpatient and Emergency of Our Hospital[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018,15(7):429-433.
[9] Li LW, Ma LF, Li SQ.Retrospective Clinical Evaluation of Anti-tuberculosis Drug Induced Liver Injury[J].Chin J Pharmacoepidemiol(药物流行病学杂志), 2016,25(12):773-776.
[10] Qiu YQ, Lu XY, Yu YS, et al.Guidance on skin allergy test of cephalosporins antibiotics in Zhejiang Province[J]. Chin J Mod Appl Pharm(中国现代应用药学),2018,35(12):1906-1908.
[11] Zhu CM, Wu M.Analysis of New and Serious Adverse Drug Reactions Reports in Our Hospital from 2007 to 2016[J]. Chin J Pharmacoepidemiol(药物流行病学杂志),2017,26(4):551-555.
[12] Lv XQ, Ma MK, Zhu Y, et al.Analysis of Leaflets' Safety Information and Adverse Reaction Monitoring Data of Chinese Patent Drugs[J]. Chin J Mod Appl Pharm(中国现代应用药学), 2019,36(4):493-497.
[13] The basic principles for clinical use of Traditional Chinese Medicine Injections[S]. 2008.
[14] Fu H, Qiu ZJ,Rong YH.Pareto Diagram Analysis on 1786 Cases of Adverse Drug Reactions/Adverse Drug Events Induced by Intravenous Medication[J]. Evaluation and analysis of drug-use in hospitals of China(中国医院用药评价与分析),2016,16(6):832-835.
[15] Ge FL, Xue CM, Sun Y, et al.Advances in Drug Epidemiology of Drug-induced Liver Injury in our Country[J]. Chinese Hepatology(肝脏),2018, 23(11):1032-1033.
[16] Chen FQ, Chen Z, Zhang JR, et al.Advances in Clinical Epidemiology of Drug-induced Liver Injury[J]. Chin J Pharmacoepidemiol(药物流行病学杂志), 2016,25(12):810-812.
[17] Lin LF, Xu LJ, Chen SZ,et al.Analysis on 74 Cases of Anaphylactic Shock Induced by Nonionic Coronary Contrast Media[J]. Chin J of Clinical Rational Drug Use(临床合理用药), 2015,8(10): 32-33.
[18] Idee JM, Pines E, Prigent P, et al.Allergy-like reactions to iodinated contrast agents. A critical analysis[J]. Fundam Clin Pharmacol, 2005, 19(3): 263-280.

某院182例严重药品不良反应/事件分析

Analysis of 182 Case of Serious Adverse Drug Reactions/events Reports in a Hospital

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	贾晋生, 刘红亮, 王青, 侯永芳, 李馨龄. 基于知识图谱联合ERNIE-DPCNN模型的药品不良反应自动关联性评价方法研究[J]. 中国药物警戒, 2024, 21(2): 163-166.
[2]	李应芬, 韩雷. 319例注射用脑蛋白水解物药品不良反应报告分析[J]. 中国药物警戒, 2024, 21(2): 195-198.
[3]	徐伟佳, 彭崎, 黄海渝, 张磊姣, 肖华, 吴雪. 285例新型抗肿瘤药物不良反应分析[J]. 中国药物警戒, 2024, 21(2): 199-203.
[4]	郭清华, 彭笑笑, 朱萍, 刘西霖, 杨颖华, 陈志海. 氨氯地平过量致多器官功能障碍综合征1例分析[J]. 中国药物警戒, 2024, 21(2): 204-207.
[5]	方美琳, 郑慧敏, 王存泽, 王凌, 阮君山. 注射用奥沙利铂致全身肌肉疼痛1例分析[J]. 中国药物警戒, 2024, 21(2): 208-210.
[6]	陈玉艳, 张明霞, 张涛, 张晋. 斯鲁利单抗注射液致间质性肺炎不良反应1例分析[J]. 中国药物警戒, 2024, 21(2): 213-215.
[7]	曹桂萍, 邓琳琳, 朱干红, 陆颖, 马爽, 陈玲玲, 刘丽丽. 天麻首乌片致严重肝损伤1例分析[J]. 中国药物警戒, 2024, 21(2): 216-218.
[8]	高云娟, 赵旭, 白天凯, 柏兆方, 王伽伯, 宋海波, 肖小河. 基于不良反应监测大数据的药品安全风险发现与识别策略[J]. 中国药物警戒, 2024, 21(1): 1-5.
[9]	郭龙鑫, 高云娟, 吴承钊, 龙敏娟, 祝胜凯, 宋海波, 赵旭, 肖小河. 基于不良反应监测大数据的中药药源性肝损伤风险信号新发现及易感因素初探[J]. 中国药物警戒, 2024, 21(1): 15-19.
[10]	蒋文硕, 杨莉. 694例癫痫医师药师联合门诊患者药品不良反应分析[J]. 中国药物警戒, 2024, 21(1): 102-106.
[11]	陈华炎, 江东波, 郭春连, 杨家琪, 黎雨欣, 蔡伟明. 326例奈玛特韦片/利托那韦片治疗新型冠状病毒感染安全性分析[J]. 中国药物警戒, 2024, 21(1): 107-110.
[12]	詹姆斯·布坎南. 用 nR 改良海氏法则及 P_ALT 评估药物性肝损伤研究进展[J]. 中国药物警戒, 2024, 21(1): 117-120.
[13]	刘赛月, 吕小琴, 周耘. 疑似药品不良反应死亡病例调查及报告实施要点[J]. 中国药物警戒, 2023, 20(9): 971-974.
[14]	里筱竹, 王蔷, 逄瑜, 张轶菁. 个例药品不良反应报告管理浅析与思考[J]. 中国药物警戒, 2023, 20(9): 975-977.
[15]	逄瑜, 刘博, 吕少俐, 王涛, 邢颖, 秦星宇, 田月洁, 吴文宇. 基于国际药物警戒经验探讨收集患者报告的意义[J]. 中国药物警戒, 2023, 20(9): 978-981.